Growing Number of Premature and Low Weight Births is Catalyzing the Fetal Monitoring Market
According to our latest market study on "Fetal Monitoring Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Method, Portability, Application, and Geography" the market was valued at US$ 3,870.9 million in 2021 and is likely to reach a value of US$ 6,438.2 million by 2028 with an estimated CAGR of 7.6% from 2022 to 2028. Fetal Monitoring Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Ultrasound Devices, Fetal Monitors, Telemetry Devices, Fetal Electrodes, Others), Portability (Portable and Non-Portable), Method (Invasive and Non-invasive), Application (Antepartum and Intrapartum), and End User (Hospitals, Obstetrics & Gynecology Clinics, and Home Care Settings), Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Fetal Monitoring Market Growth Report | Trends, Size & Forecasts 2030
Download Free Sample
Source: The Insight Partners Analysis
The increase in preterm and low-weight births is one of the major factors driving the growth of the fetal monitoring market. With the increasing number of births, many complications are associated with prematurity, resulting in deaths. Prematurity is defined as a live birth before 37 weeks of gestation, with a birth weight of less than 2500 g being considered a low weight birth. According to a study published in the July 2020 International Journal of Gynecology & Obstetrics, titled "Global Burden of Preterm Birth," around fifteen million babies are born prematurely worldwide, resulting in a global preterm birth rate of approximately 11%. Additionally, in the US, according to the Centers for Disease Control and Prevention, a November 2021 updated article titled "Preterm Birth" reported that one in ten children born in 2020 were born prematurely. In addition, the incidence of diseases in newborns has also increased. These factors have increased the market demand for fetal monitoring devices.
Preterm birth remains a significant public health problem, contributing to 75% of worldwide neonatal mortality. Low birth weight (LBW) is an important but imperfect surrogate for preterm birth when the accurate determination of gestational age is impossible. While there is overlap between preterm births and LBW newborns, those who are both preterm and LBW are at the highest risk for adverse neonatal outcomes. The World Health Organization (WHO) estimates that over fifteen million infants are born prematurely yearly, and around one million die from premature problems. According to the World Health Organization, more than 60% of preterm births occur in South Asia and Africa. The preterm birth rate in low-income countries was around 12%, compared to 9% in higher-income countries. Approximately 3,519,100 preterm births were recorded in India in 2018. Therefore, the increasing number of preterm births and increased survival concerns fuel the demand for fetal monitoring devices to manage the complications associated with these preterm births.
Technological advances and innovations in the 21st century aimed at developing highly efficient tools for effective fetal care have proven significant in managing preterm births. Several multi-chain hospitals have opened specialized pediatric clinics in different locations to increase access to fetal and neonatal clinics. For example, in 2015, Seattle Children's Hospital announced the opening of the Seattle Children's South Clinic regional clinic in Pierce and South King counties. It aimed to provide better access to specialist fetal and neonatal clinics and services.
Increasing pregnancy complications such as infections, pre-eclampsia, fetal growth restriction, associated efforts to increase fetal and maternal survival rates, and advances in fetal care are the major factors driving global sales of fetal monitoring devices. As companies worldwide increasingly focus on research initiatives, expansion is the order of the day. Monitoring the fetus is one of the complex tasks that can cause complications. Research efforts to develop advanced technological devices remain essential to manufacturers. Rapid technological advances favor companies that bring blue spectrum radiation sources and user-friendly control panel phototherapy devices to market.
Koninklijke Philips N.V.; FUJIFILM SonoSite, Inc.; Medtronic Plc; Siemens Healthineers; GE Healthcare; EDAN Diagnostics, Inc.; Natus Medical Incorporated; Neoventa Medical AB; CONTEC Medical Systems Co., Ltd.; and The Cooper Companies, Inc. are among the key market players profiled during the study. Several other major companies were studied and analyzed during this research study to get a holistic view of the fetal monitoring market and its ecosystem.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com